FDA Accepts ANDA for Esomeprazole Magnesium by Marksans Pharma
The FDA has accepted the Abbreviated New Drug Application (ANDA) for Esomeprazole Magnesium submitted by Marksans Pharma.
Asset / Drug
Drug and asset intelligence for Esomeprazole with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
Proton Pump Inhibitor
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.